CML cells, such as K562 and Lucena-1, are characterized by the presence of the Philadelphia chromosome translocation that contains the BCR-ABL hybrid gene, which encodes an oncogenic fusion protein Bcr-Abl. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.